Article info
PDFScientific correspondence
Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation
- Correspondence to: David Keegan, Department of Pathology, Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK; d.keegan{at}ucl.ac.uk
Citation
Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation
Publication history
- Accepted July 2, 2001
- First published January 1, 2002.
Online issue publication
March 22, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 British Journal of Ophthalmology